BILL ANALYSIS
------------------------------------------------------------
|SENATE RULES COMMITTEE | ACR 168|
|Office of Senate Floor Analyses | |
|1020 N Street, Suite 524 | |
|(916) 651-1520 Fax: (916) | |
|327-4478 | |
------------------------------------------------------------
THIRD READING
Bill No: ACR 168
Author: Galgiani (D)
Amended: As introduced
Vote: 21
WITHOUT REFERENCE TO COMMITTEE OR FILE
ASSEMBLY FLOOR : 78-0, 08/12/10 (Consent) - See last page
for vote
SUBJECT : Chronic obstructive pulmonary disease awareness
SOURCE : Boehringer-Ingelheim Pharmaceuticals, Inc.
DIGEST : This resolution encourages the Department of
Health Care Services to partner with private entities to
improve education regarding chronic obstructive pulmonary
disease. In addition, this resolution designates November
2010 as Chronic Obstructive Pulmonary Disease Awareness
Month.
ANALYSIS : Resolution findings:
1. Chronic obstructive pulmonary disease (COPD), also known
as chronic bronchitis and emphysema, is the fourth
leading cause of death in the United States and is the
only one of the top five causes of death whose
prevalence and death rate is rising.
2. COPD is a chronic and progressive disease that impacts
CONTINUED
ACR 168
Page
2
an estimated 24 million Americans each year,
approximately five million of whom are residents of
California, and an estimated 1.6 million of whom suffer
directly from the disease.
3. In 2004, the national annual cost for COPD was estimated
to be $37 billion and in that same year, COPD caused
approximately 121,000 deaths nationwide.
4. Many patients suffering with COPD are not diagnosed
until they have reached an advanced stage of COPD, which
often includes a disabling degree of lung dysfunction.
5. A diagnostic test for COPD, known as spirometry, is
available for office use, allowing early diagnosis of
COPD.
6. Early diagnosis and management of COPD can effectively
reduce the overall financial burden of this illness on
publicly funded health care programs, including
Medi-Cal.
7. Achieving early diagnosis and proper management of COPD
among California's diverse populations, within the
Medi-Cal program as well as other publicly funded health
care programs, requires overcoming cultural, language,
and literacy challenges.
8. Proper management of COPD can lead to an improved
quality of life and self-sufficiency for patients who
receive publicly funded benefits.
9. The "Healthy People 2010" project of the Centers for
Disease Control and Prevention and the National
Institutes of Health concludes that, while primary care
physicians are in a key position to provide optimal care
to patients with COPD and to provide counseling during
clinical or health center visits, primary care
physicians need to be trained in the latest methods for
diagnosing and treating the disease.
Background
COPD is the term for chronic bronchitis, emphysema and a
CONTINUED
ACR 168
Page
3
range of other respiratory disorders. It is a source of
significant health problems in the United States and
throughout the world. Many aspects of COPD are preventable
and treatable. COPD is diagnosed via lung function tests.
Health management strategies include smoking cessation,
vaccinations, rehabilitation, and inhaler use. Patients
with severe symptoms sometimes require long-term oxygen
therapy or lung transplantation.
Note:This bill is sponsored by Boehringer-Ingelheim
Pharmaceuticals, Inc., an international company
headquartered in Germany. The company markets several
treatments for COPD including Spiriva, Atrovent,
Combinvent, and Duovent.
FISCAL EFFECT : Fiscal Com.: Yes
According to the Assembly Appropriations Committee
analysis, this resolution has no direct fiscal impact to
the Department of Health Care Services.
SUPPORT : (Verified 8/24/10)
Boehringer-Ingelheim Pharmaceuticals, Inc. (source)
GlaxoSmithKline
Talecris Biotherapeutics
ARGUMENTS IN SUPPORT : Boehringer-Ingelheim
Pharmaceuticals, Inc. (BIPI), sponsor of this resolution
states, "COPD is a slowly debilitating disease, whose
prevalence and deadliness is on the rise in the U.S. and
internationally. Approximately 1.6 million Californians
are direct suffers of COPD which progressively constricts
and damages airways. Alarmingly, the World Health
Organization (WHO) reports that, on average, one person
every 10 seconds dies from COPD complications.
"COPD is largely preventable, but not curable. Appropriate
management improves symptoms and helps people improve their
quality of life. BIPI is dedicating substantial research
resources to investigate possible new interventions that
target novel targets in COPD."
CONTINUED
ACR 168
Page
4
ASSEMBLY FLOOR :
AYES: Adams, Ammiano, Anderson, Arambula, Bass, Beall, Bill
Berryhill, Tom Berryhill, Blakeslee, Block, Blumenfield,
Bradford, Brownley, Buchanan, Caballero, Charles
Calderon, Carter, Chesbro, Conway, Cook, Coto, Davis, De
La Torre, De Leon, DeVore, Eng, Evans, Feuer, Fletcher,
Fong, Fuentes, Fuller, Furutani, Gaines, Galgiani,
Garrick, Gatto, Gilmore, Hagman, Hall, Harkey, Hayashi,
Hernandez, Hill, Huber, Huffman, Jeffries, Jones, Knight,
Lieu, Logue, Bonnie Lowenthal, Ma, Mendoza, Miller,
Monning, Nava, Nestande, Niello, Nielsen, V. Manuel
Perez, Portantino, Ruskin, Salas, Saldana, Silva,
Skinner, Smyth, Solorio, Audra Strickland, Swanson,
Torlakson, Torres, Torrico, Tran, Villines, Yamada, John
A. Perez
NO VOTE RECORDED: Norby, Vacancy
CTW:nl 8/28/10 Senate Floor Analyses
SUPPORT/OPPOSITION: SEE ABOVE
**** END ****
CONTINUED